A 2-mo-old infant born to a mother with Graves’disease and having symptoms of thyrotoxicosis was started on antithyroid drugs.Life-threatening hypocalcaemia requiring high-dose calcium infusions developed 1 mo after ...A 2-mo-old infant born to a mother with Graves’disease and having symptoms of thyrotoxicosis was started on antithyroid drugs.Life-threatening hypocalcaemia requiring high-dose calcium infusions developed 1 mo after starting therapy.Serum alkaline phosphatase and paratharmone levels were elevated.This communication may serve to alert treating physicians about this rare complication in infants with thyrotoxicosis after initiation of antithyroid therapy.Conclusion:Severe hypocalcaemia may follow initiation of antithyroid therapy in infants with thyrotoxicosis.展开更多
文摘A 2-mo-old infant born to a mother with Graves’disease and having symptoms of thyrotoxicosis was started on antithyroid drugs.Life-threatening hypocalcaemia requiring high-dose calcium infusions developed 1 mo after starting therapy.Serum alkaline phosphatase and paratharmone levels were elevated.This communication may serve to alert treating physicians about this rare complication in infants with thyrotoxicosis after initiation of antithyroid therapy.Conclusion:Severe hypocalcaemia may follow initiation of antithyroid therapy in infants with thyrotoxicosis.
